Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2010
12/15/2010EP2261209A1 Novel crystalline forms of 4-[4-[4- hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenene acetic acid and its hydrochloride
12/15/2010EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260863A1 Prophylactic/therapeutic agent for infectious disease
12/15/2010EP2260855A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs
12/15/2010EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1778724B1 Antiangiogenic peptides
12/15/2010EP1761253B1 Hyaluronic acid in the enhancement of lens regeneration
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1534667B1 Muscarinic agonists
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010CN1993362B 稠合的杂环化合物 Fused heterocyclic compound
12/15/2010CN1956716B Medicine capable of inhibiting activation of transcription factor KLF5
12/15/2010CN1935134B Combination comprising combretastatin and anticancer agents
12/15/2010CN1929829B (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
12/15/2010CN1919848B bilobalide K and complex thereof, preparation method and use for the same
12/15/2010CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
12/15/2010CN101918363A Phenyl acetamide derivative
12/15/2010CN101918001A Combination therapies using melengestrol acetate and zilpaterol or its salts
12/15/2010CN101917999A Modulation of protein trafficking
12/15/2010CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
12/15/2010CN101912550A Chinese medicinal herb for curing virgin false fetus
12/15/2010CN101912411A Stone needle health care spray
12/15/2010CN101912399A Radiotherapy enhancer
12/15/2010CN101912382A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
12/15/2010CN101912381A Methods and compositions for treating ectoparasite infestation
12/15/2010CN101450048B Acute hypoxia injury resistance use of teprenone
12/15/2010CN101057909B Composition with multiple health care functions and its preparation method
12/15/2010CN101012211B Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof
12/14/2010US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851507 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis
12/14/2010US7851503 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/14/2010US7851491 Modified bio-related substance, process for producing the same, and intermediate
12/14/2010US7851447 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve
12/14/2010US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7850996 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
12/14/2010US7850976 Insulin resistance improving agents
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2624847C Dermatitis treating agent
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2485424C Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
12/14/2010CA2478811C Tasted masked veterinary solid compositions
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2462376C Liposome loading with metal ions
12/14/2010CA2446673C Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2433858C Purine derivatives as purinergic receptor antagonists
12/14/2010CA2417484C Elongase genes and uses thereof
12/14/2010CA2412723C Benzothiazolyl ppar-gamma modulators
12/14/2010CA2400124C Tnf-.alpha. inhibitors
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2355939C Antihistaminic spiro compounds
12/14/2010CA2336781C Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
12/14/2010CA2326764C Acylbenzoxazines for enhancing synaptic response(s)
12/14/2010CA2233316C Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
12/09/2010WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010140531A1 Pharmaceutical composition, food or beverage, and methods for these products
12/09/2010WO2010140409A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
12/09/2010WO2010140339A1 Heterocyclic compound
12/09/2010WO2010100060A3 Method for increasing endogenous plasmalogen levels in mammals
12/09/2010US20100311833 Physiological coolants based on lactoyl esters of menthyl lactate
12/09/2010US20100311830 Menthol Replacement
12/09/2010US20100311829 Novel Therapeutic Uses of Beta-3 Adrenergic Receptor Agonist Derivatives in Particular to Modulate Apoptosis
12/09/2010US20100311824 Modulation of forkhead box o1a expression
12/09/2010US20100311821 Synthetic vector
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311811 Rna-mediated epigenetic regulation of gene transcription
12/09/2010US20100311771 Method of treating movement disorders using barbituric acid derivatives
12/09/2010US20100311665 Method and Composition for Potentiating an Opiate Analgesic
12/09/2010US20100311662 Treatment of Acute Coronary Syndrome with an Exendin
12/09/2010US20100311651 Use of glp-1 compound for treatment of critically ill patients
12/09/2010US20100310663 Pharmaceutical compositions comprising nanoparticles and a resuspending material
12/09/2010US20100310544 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310483 Compositions Comprising Phosphoric Acid Ester And Hydrophobically Modified, Crosslinked Anionic Polymers
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310461 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258394A1 Oral dosage form comprising a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
12/08/2010EP2258393A1 Abc transporter protein expression inhibitor
12/08/2010EP2258378A1 Anti-tumor agent comprising cytidine derivative and carboplatin
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 1564